Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/6/2007
1.
Phase II Study of Rhenium-186 HEDP in Prostate Cancer Patients with Symptomatic Skeletal Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 21
MSKCC-89129A1
NCI-V90-0033
Last Modified:
11/1/1991
2.
Phase II Study of Repeated Administrations of Rhenium-186 HEDP in Patients with Skeletal Metastases From Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 21
MSKCC-90087
NCI-V90-0149
Last Modified:
2/1/1991
3.
Phase I Study of Escalating Doses of Rhenium-186 HEDP in Patients with Skeletal Metastases from Prostate Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 21
MSKCC-90088
NCI-V90-0150
Last Modified:
7/1/1991
4.
Phase I Study of Escalating Activities of Rhenium-186 HEDP in Patients with Skeletal Metastases from Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
over 21
MSKCC-91004
NCI-V91-0072
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute